AAArjun Aggarwal

Arjun Aggarwal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Arjun Aggarwal has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Electrocardiographic artificial intelligence for prediction of pacemaker implantation after transcatheter aortic valve replacement: a retrospective multi-center study Supplementary Appendix

    by Ibrahim Karabayir, Arjun Aggarwal, Oguz Akbilgic, Turgay Celik, Prashant Bhave, Michael J. Rinaldi, David Herrington, David Zhao

    Background: Permanent pacemaker (PPM) implantation remains a common complication after transcatheter aortic valve replacement (TAVR). Existing clinical and imaging-based risk prediction models showing limited and inconsistent performance. We evaluated whether a pre-procedural ECG-based artificial intelligence (ECG-AI) model predicts 30-day PPM post-TAVR. Methods: In this retrospective multicenter study, a 1-dimensional convolutional neural network was trained on 34,745 ECGs from 5,932 patients with moderate-to-severe aortic stenosis (proxy cohort) to enable prediction of 30-day PPM implantation after TAVR using preprocedural ECGs. Zero-shot external validation was performed in two independent TAVR cohorts (Atrium Health Wake Forest Baptist [AHWFB] and Sanger Heart and Vascular Institute [SHVI]) without recalibration or fine-tuning. Model performance was assessed using discrimination and calibration metrics, with subgroup analyses by valve platform, clinical factors, and ECG-to-TAVR timing. Incremental and independent prognostic value was evaluated using multivariable logistic regression incorporating clinical and imaging covariates. Findings: The model was evaluated in two heterogeneous TAVR cohorts (AHWFB, n=823; SHVI, n=162) with differences in baseline characteristics and valve use, demonstrating moderate but consistent discrimination across cohorts (AHWFB: AUROC 0·67 [0·61–0·73], Brier 0·11 [0·09–0·13]; SHVI: AUROC 0·78 [0·67–0·88], Brier 0·07 [0·04–0·11]) with high negative predictive value (0·92–0·99). Performance remained stable for ECGs obtained within 0–2 days pre-TAVR (AUROC ~0·75–0·78) and in Sapien-only analyses (AHWFB: 0·77 [0·70–0·84]; SHVI: 0·79 [0·68–0·89]). In multivariable models, baseline covariates modestly improved discrimination (ΔAUC ≤0·06 in SHVI), while ECG-AI remained the only independent and consistent predictor (OR 1·36–2·18). Interpretation: An ECG-AI model trained in a large cohort demonstrated robust, transferable prediction of 30-day PPM post-TAVR using pre-procedural ECGs across multiple TAVR cohorts without recalibration. It captured prognostic information beyond traditional baseline risk factors and showed consistent independent and incremental predictive value.

  • VENTRICULAR FIBRILLATION: A RARE INITIAL PRESENTATION OF THYROTOXIC PERIODIC PARALYSIS

    by Nisha Soneji, Arjun Aggarwal, Nabeel Saghir, Yan Liu


  • COMPARATIVE EFFECTIVENESS OF VASOPRESSORS AND INOTROPES IN CARDIOGENIC SHOCK

    by Arjun Aggarwal, Manoj Thangam, Richard Bach, John Lasala, Sunil Rao, C. Michael Gibson, David Kandzari, Jason Katz, Elena Deych, Pratik Doshi, et al.